Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03869411
Other study ID # 201812135RINB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 15, 2019
Est. completion date July 31, 2020

Study information

Verified date December 2020
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the first year of this three-year plan is to analyze and compare the muscle quality of lower limb muscle (microcirculation, muscle performance and mechanical characteristics) and maximal aerobic exercise capacity in treadmill exercise tests for diabetic and non-diabetic cases. The hypotheses are:1) the muscle quality of lower limb muscle and maximal aerobic exercise capacity are different between participate with diabetic and non-diabetic, 2) the effect of the three-month aerobic exercise intervention or home exercise on the characteristics of the muscle quality are different , and 3) intrinsic factors (such as age, BMI, and HDL) and characteristics of specific FTO genes are influenced the training outcomes.


Description:

Participants with diabetes will attend an 12-week aerobic exercise intervention or home exercise if the exercise test result of the maximum rate of oxygen consumption is fair or poor. Assessments will be taken before and after the training program, which including muscle strength, stiffness, quality, microcirculation and exercise capacity. Comparisons between the pre-training and post-training condition will be made for each groups. And the assessments also compare with the healthy control group.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date July 31, 2020
Est. primary completion date May 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria: - Diabetes group: 1) Age between 30-70 years of old, 2) type 2 diabetes. - Healthy control group: 1) Age between 30-70 years of old, 2) without diabetes Exclusion Criteria: - history of moderate-severe somatic or autonomic neuropathy, cardiovascular disease, preproliferative or proliferative retinopathy, and chronic renal failure - unable to perform the programs or assessments - other systematic diseases

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
supervised aerobic exercise or home-based aerobic exercise
The aerobic exercise and home exercise programs are consisted of 50 minutes per time, 3 times per weeks and totally 3 months. The aerobic exercise group will perform the exercise program under one physical therapy and one aerobic dance teacher supervised. The home exercise group will do the exercise program based on ACSM's aerobic exercise recommend, and will used the home exercise record form to make sure their cooperation.

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

References & Publications (3)

Bacchi E, Negri C, Zanolin ME, Milanese C, Faccioli N, Trombetta M, Zoppini G, Cevese A, Bonadonna RC, Schena F, Bonora E, Lanza M, Moghetti P. Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized control — View Citation

Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B; American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and t — View Citation

Prior SJ, Blumenthal JB, Katzel LI, Goldberg AP, Ryan AS. Increased skeletal muscle capillarization after aerobic exercise training and weight loss improves insulin sensitivity in adults with IGT. Diabetes Care. 2014 May;37(5):1469-75. doi: 10.2337/dc13-2 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary index of muscle stiffness elastography was used, units on kPa Change from Baseline muscle quality at 3 months
Primary muscle strength of knee extensor and plantarflexor Dynamometer was used to measure muscle strength, units on kilograms Change from Baseline functional performance at 3 months
Primary Relative sliding of muscles B mode sonography was used, units on mm/s Change from Baseline muscle quality at 3 months
Primary muscle microcirculation Near-infrared spectroscopy was used to measure oxygen saturation on muscle, units on percentage Change from Baseline muscle quality at 3 months
Primary maximum rate of oxygen consumption Bruce treadmill protocol was used in the maximal exercise testing, maximum rate of oxygen consumption record as ml/kg/min Baseline
Secondary characteristics of specific FTO genes rs9939609 SNP analysis, record as TT or TA or AA type Baseline
Secondary physical activity level self report the ability of walking one-fourth of a mile, record as degree of difficulty: none, some difficulty, much difficulty, inability Change from Baseline functional performance at 3 months
Secondary BMI weight and height will be combined to report BMI in kg/m^2 Change from Baseline functional performance at 3 months
Secondary blood glucose level Hemoglobin A1c (HbA1c), unit on percentage Change from Baseline functional performance at 3 months
Secondary blood cholesterol total cholesterol, units on mg/dL Change from Baseline functional performance at 3 months